Literature DB >> 17584325

Psoriasiform and pustular eruption induced by infliximab.

Hidetoshi Takahashi1, Yoshio Hashimoto, Akemi Ishida-Yamamoto, Toshifumi Ashida, Yutaka Kohgo, Hajime Iizuka.   

Abstract

Although antitumor necrosis factor (anti-TNF)-alpha therapy provides beneficial effects on various chronic inflammatory skin diseases including psoriasis, cutaneous side-effects have also been reported. We describe four patients who showed psoriasiform eruption following anti-TNF-alpha therapy (infliximab) for Crohn's disease. In all patients, Crohn's disease had responded well to infliximab. Three patients developed plaque-type psoriasiform eruption on the trunk and four extremities, while one patient showed pustular eruption on the palms and soles accompanied with plaque-type psoriasis. In all these patients, skin lesions subsided with topical application of corticosteroid ointment or psoralen plus ultraviolet A treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584325     DOI: 10.1111/j.1346-8138.2007.00312.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

Review 1.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

2.  Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease.

Authors:  Byung Cheol Park; Hyun Jung Lim; Byung Soo Kim; Weon Ju Lee; Do Won Kim; Seok-Jong Lee
Journal:  Ann Dermatol       Date:  2009-02-28       Impact factor: 1.444

3.  Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis.

Authors:  Irene Pontikaki; Edit Shahi; Lucretia Adina Frasin; Raffaele Gianotti; Carlo Gelmetti; Valeria Gerloni; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  Paradoxical skin lesions induced by anti-TNF-α agents in SAPHO syndrome.

Authors:  Chen Li; Xia Wu; Yihan Cao; Yueping Zeng; Weihong Zhang; Shuo Zhang; Yuehua Liu; Hongzhong Jin; Wen Zhang; Li Li
Journal:  Clin Rheumatol       Date:  2018-04-03       Impact factor: 2.980

5.  Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn's disease.

Authors:  Hitoshi Amano; Reikei Matsuda; Tomohiko Shibata; Daisuke Takahashi; Shinichiro Suzuki
Journal:  Biologics       Date:  2017-05-22

6.  The changing face of spondyloarthropathies under TNF α blockade.

Authors:  Ori Elkayam; Irena Litinsky; David Levartovsky; Dan Caspi
Journal:  Open Rheumatol J       Date:  2008-11-14

7.  Successful treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis and paradoxical skin lesions by Tripterygium wilfordii hook f: a case report.

Authors:  Xinlu Zhang; Xia Wu; Chen Li
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.